April 2014 FDA Recall Drug by Cubist Pharmaceuticals, Inc.
D-1382-2014 - Presence of Particulate Matter

This Class I drug recall was voluntarily initiated by Cubist Pharmaceuticals, Inc. on April 17, 2014 for the product Drug. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1382-2014

Reason for Recall
Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard.
Initiated
04-17-2014
Reported
06-18-2014
Quantity
51,500 vials

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Cubist Pharmaceuticals, Inc.
Nationwide and Puerto Rico.
CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, NDC 67919-011-01, UPC 3 67919-011-01 6.

Batch or Lot Expiration Information

Lot# : 280453F, Exp 04/16